Emkay Global Financial Services has come out with its report on investment in 8 largecap stocks.

Buy Dr Reddys Labs; target of Rs 2044: Firstcall Research

Firstcall Research is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 2044 in its December 4, 2012 research report.

Buy or sell: Emkay's trading tips for Mahurat trading

Emkay Global Financial Services has come out with its report on conviction ideas.

Accumulate Dr Reddys; target of Rs 1944: Dolat Capital

Dolat Capital is bullish on Dr Reddys Laboratories (DRL) and has recommended accumulate rating on the stock with a target of Rs 1944 in its October 31, 2012 research report.

Accumulate Dr Reddys Labs; target of Rs 1859: Angel Broking

Angel Broking is bullish on Dr Reddys Labs and has recommended accumulate rating on the stock with a target of Rs 1859 in its October 30, 2012 research report.

Buy Dr Reddys Labs; target of Rs 2038: PLilladher

Prabhudas Lilladher is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 2038 in its October 30, 2012 research reports.

Hold Dr Reddys Labs; target of Rs 1700: Emkay

Emkay Global Financial Services has recommended hold rating on Dr Reddys Labs with a target of Rs 1700, in its July 19, 2012 research report.

Buy Dr Reddys Labs; target of Rs 1824: Firstcall Research

Firstcall Research is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1824 in its July 20, 2012 research report.

Buy Dr Reddys Laboratories; target Rs 1931: Dolat Capital

Dolat Capital is bullish on Dr Reddys Laboratories (DRL) and has recommended buy rating on the stock with a target price of Rs 1931 in its July 20, 2012 research report.

Buy Dr Reddys Labs; target of Rs 2056: Motilal Oswal

Motilal Oswal is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 2056 in its July 12, 2012 research report.

Accumulate Dr Reddys Labs; target of Rs 1938: Dolat Capital

Dolat Capital is bullish on Dr Reddys Labs and has recommended accumulate rating on the stock with a target of Rs 1938 in its May 15, 2012 research report.

Hold Dr Reddys Labs; target of Rs 1700: Emkay

Emkay Global Financial Services has recommended hold rating on Dr Reddys Labs with a target of Rs 1700, in its May 11, 2012 research report.

Buy Dr Reddys Labs; target Rs 1,730: IIFL

IIFL is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 1,730 in its March 13, 2012 research report.

Buy Dr Reddys Labs; target of Rs 1864: Firstcall Research

Firstcall Research is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1864 in its February 16, 2012 research report.

Buy Dr Reddys Laboratories; target of Rs 1,920: Angel

Angel Broking is bullish on Dr Reddys Laboratories (DRL) and has recommended buy rating on the stock with a target of Rs 1,920 in its February 3, 2012 research report.

Hold Dr Reddys Laboratories; target Rs 1650: Emkay

Emkay Global Financial Services has maintained hold rating on Dr Reddys Laboratories with a target price of Rs 1650 in its February 3, 2012 research report.

Sell Dr Reddys Labs; target of Rs 1519: PINC Research

PINC Research is bearish on Dr Reddys Labs and has recommended sell rating on the stock with a target of Rs 1519 in its February 3, 2012 research report.

Buy Dr Reddys Laboratories; target Rs 1,689: IIFL

IIFL is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 1,689 in its November 14, 2011 research report.

Hold Dr Reddys Laboratories; target Rs 1604: Emkay

Emkay Global Financial Services has recommended hold rating on Dr Reddys Laboratories with a target of Rs 1604, in its October 25, 2011 research report.

Buy Dr Reddys Labs; target of Rs 1920: Angel Broking

Angel Broking is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1920 in its October 28, 2011 research report.

Buy Dr Reddys Labs; target of Rs 1720: Firstcall Research

Firstcall Research is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1720 in its September 17, 2011 research report.

Buy Dr Reddys Labs; target of Rs 1787: KRChoksey

KRChoksey is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1787 in its September 26, 2011 research report.

Hold Dr Reddys Labs; target of Rs 1787: KRChoksey

KRChoksey has recommended hold rating on Dr Reddys Labs with a target of Rs 1787, in its July 26, 2011 research report.

Buy Dr Reddys Labs; target of Rs 1920: Angel Broking

Angel Broking is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1920 in its July 20, 2011 research report.

Accumulate Dr Reddys Labs; target of Rs 1750: Emkay

Emkay Global Financial Services is bullish on Dr Reddys Labs and has recommended accumulate rating on the stock with a target of Rs 1750 in its July 20, 2011 research report.